Individuals with interstitial lung disease face a significantly higher risk of developing lung cancer than those without the ...

Many lung cancers in nonsmokers have no known cause and are discovered only by chance.

CyPath® Lung detected a Stage 1A neuroendocrine tumor in a patient's lung when imaging and other adjuvant tools could not.

Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...

Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med. | Ahead of the 10-year ...

Seventy percent of Asian American and Pacific Islander women diagnosed with lung cancer were non- or never-smokers, ...

People living in high pollution areas may rack up DNA glitches that trigger lung cancer, scientists suggest July 2 in Nature. Those glitches can include mutations that hobble the very genes that ...

Canada grants bioAffinity Technologies new patent that protects its proprietary technology that powers its flagship product, ...

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions continue to assist pulmonologists.

Tagrisso with chemo significantly improved survival and progression-free outcomes versus Tagrisso alone in newly diagnosed ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had a cigarette could be at risk of the deadly disease.

NIH study finds particulate air pollution significantly increases mutations in lung cancer cases among nonsmokers, raising ...